These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19446589)

  • 1. Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge.
    Platt R; Widel PW; Kesl LD; Roth JA
    Vaccine; 2009 Jul; 27(33):4508-19. PubMed ID: 19446589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
    Zimmerman AD; Boots RE; Valli JL; Chase CC
    J Am Vet Med Assoc; 2006 Jun; 228(11):1757-61. PubMed ID: 16740078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela
    Platt R; Kesl L; Guidarini C; Wang C; Roth JA
    Vet Immunol Immunopathol; 2017 May; 187():20-27. PubMed ID: 28494925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves.
    Ellis J; West K; Cortese V; Konoby C; Weigel D
    J Am Vet Med Assoc; 2001 Aug; 219(3):351-6. PubMed ID: 11497051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus.
    Cortese VS; West KH; Hassard LE; Carman S; Ellis JA
    J Am Vet Med Assoc; 1998 Nov; 213(9):1312-9. PubMed ID: 9810390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal antibody blocks humoral but not T cell responses to BVDV.
    Endsley JJ; Roth JA; Ridpath J; Neill J
    Biologicals; 2003 Jun; 31(2):123-5. PubMed ID: 12770543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
    Xue W; Mattick D; Smith L; Maxwell J
    Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
    Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
    Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination.
    Endsley JJ; Quade MJ; Terhaar B; Roth JA
    Vet Ther; 2002; 3(4):364-72. PubMed ID: 12584672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers.
    Downey-Slinker ED; Ridpath JF; Sawyer JE; Skow LC; Herring AD
    Vaccine; 2016 Sep; 34(42):5053-5059. PubMed ID: 27601344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
    Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
    BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies.
    van Drunen Littel-van den Hurk S; Lawman Z; Wilson D; Luxembourg A; Ellefsen B; van den Hurk JV; Hannaman D
    Vaccine; 2010 Sep; 28(39):6445-54. PubMed ID: 20670907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.